Skip to main content

Table 2 Development of Diagnostic Rule 2.

From: A data review and re-assessment of ovarian cancer serum proteomic profiling

Consecutive M/Z M/Z Wilcoxon p-value Rule 2
5534 2665.397 4.06E-09 S
6372 3534.072 1.26E-07  
6753 3969.469 4E-07 S
6772 3991.844 6.87E-09 S
6782 4003.645 1.87E-12 S
6802 4027.3 6.21E-10 S
6814 4041.526 1.86E-07  
6823 4052.213 8.33E-07  
6827 4056.967 9.38E-07 S
6836 4067.673 3.9E-07  
6852 4086.742 4.11E-07  
6934 4185.17 6.56E-09  
7383 4744.889 1.71E-07 S
7449 4830.124 2.89E-07  
7468 4854.802 8.22E-07  
7508 4906.962 5.45E-07  
7606 5035.93 1.41E-07  
8707 6599.823 4.96E-07  
8839 6801.495 6.46E-09 S
9439 7756.437 2.66E-07  
9457 7786.054 4.58E-07 S
9483 7828.934 6.23E-07  
9607 8035.058 4.94E-10  
9793 8349.266 2.04E-08 S
12910 14511.46 6.4E-07  
13036 14796.14 3.95E-07 S
13113 14971.48 1.76E-07  
13201 15173.13 7.88E-09  
13537 15955.47 3.13E-07 S
13987 17034.05 4.53E-09 S
  1. The M/Z values were sorted by M/Z values greater than 2,000 and p-values less than 10-6. Consecutive M/Z is the numerical order of the M/Z value between 1 and 15,154. The M/Z values were then binned as described in the text, and the most significant consecutive M/Z score from each of the 30 bins was selected. M/Z values that were selected by the stepwise discriminant analysis are designated "S" in the rightmost column.